|
|
Volumn 39, Issue 6, 2014, Pages 750-751
|
|
Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
CERTOLIZUMAB PEGOL;
COLCHICINE;
CYCLOSPORIN A;
DAPSONE;
ETANERCEPT;
IMMUNOGLOBULIN;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PREDNISONE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
THALIDOMIDE;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOSUPPRESSIVE AGENT;
MACROGOL DERIVATIVE;
MONOCLONAL ANTIBODY;
ADULT;
BODY SURFACE;
CASE REPORT;
DERMATITIS;
FEMALE;
GLOMERULONEPHRITIS;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PYODERMA GANGRENOSUM;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
VASCULITIS;
ARTHRITIS, RHEUMATOID;
COMPLICATION;
TREATMENT OUTCOME;
YOUNG ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ARTHRITIS, RHEUMATOID;
FEMALE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
IMMUNOSUPPRESSIVE AGENTS;
POLYETHYLENE GLYCOLS;
PYODERMA GANGRENOSUM;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84904423382
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/ced.12393 Document Type: Letter |
|
Times cited : (18)
|
|
References (5)
|
